Tilray Brands (NASDAQ:TLRY) Trading 4.2% Higher – What’s Next?

22 Apr 2026, 20:04 by Renee Jackson · The Cerbat Gem

Shares of Tilray Brands, Inc. (NASDAQ:TLRY – Get Free Report) traded up 4.2% on Monday . The company traded as high as $7.23 and last traded at $7.15. 5,075,251 shares traded hands during mid-day trading, an increase of 77% from the average session volume of 2,860,661 shares. The stock had previously closed at $6.86.

Trending Headlines about Tilray Brands

Here are the key news stories impacting Tilray Brands this week:

Positive Sentiment: Reports the U.S. Justice Department will loosen cannabis restrictions sparked a sector-wide rally that lifted Tilray shares as investors price in a regulatory catalyst that would expand U.S. market opportunity and margin potential. Curaleaf and More Cannabis Stocks Soar. A Regulatory Breakthrough Is Coming.
Positive Sentiment: Political momentum also surfaced after reports that former President Trump urged rapid reclassification of cannabis, reinforcing the regulatory narrative and prompting short-term buying and bullish options positioning. Tilray Stock Pops on New Trump-Driven Cannabis Hopes. Should You Chase the Rally?
Positive Sentiment: Technical and research commentary points to a recovery setup: market write-ups highlight an early breakout and momentum that could carry TLRY higher if regulatory progress continues. Tilray Brands (TLRY) Price Forecast: Cannabis Rescheduling Fuels Recovery
Positive Sentiment: Unusually large options activity: ~45,077 call contracts were bought (about +89% vs. typical daily call volume), indicating speculative bullish bets that can amplify upside moves in the underlying stock.
Positive Sentiment: Analyst optimism: Roth Capital published a bullish note suggesting Tilray could rally >40% over 12 months based on improving fundamentals and the regulatory outlook, which can attract momentum and retail interest. 1 Wall Street Analyst Says Tilray Stock Could Jump Over 40%. Should You Believe It?
Neutral Sentiment: Trading was briefly halted on a LULD (Limit Up/Limit Down) pause around 11:49 AM — a mechanical volatility control that indicates rapid price movement but doesn’t change the underlying drivers. (No external link provided.)
Negative Sentiment: Insider selling: Director David G. Hopkinson sold 33,556 shares at an average $6.94 on April 21. Insider sales can be interpreted by some investors as a cautionary signal, even though they may be routine or pre-planned. Form 4 — David G. Hopkinson Sale

Analysts Set New Price Targets

A number of research firms have recently commented on TLRY. Roth Mkm raised Tilray Brands from a “neutral” rating to a “buy” rating and set a $10.00 price target for the company in a report on Thursday, April 2nd. ATB Cormark Capital Markets reduced their price objective on Tilray Brands from $9.50 to $9.00 and set a “sector perform” rating on the stock in a research note on Thursday, April 2nd. Zacks Research upgraded Tilray Brands from a “strong sell” rating to a “hold” rating in a research report on Wednesday, February 11th. Weiss Ratings reissued a “sell (d-)” rating on shares of Tilray Brands in a research note on Wednesday, January 21st. Finally, Canaccord Genuity Group assumed coverage on shares of Tilray Brands in a report on Tuesday, January 27th. They issued a “hold” rating for the company. Three investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Tilray Brands has a consensus rating of “Hold” and an average target price of $11.50.

Get Our Latest Stock Report on TLRY

Tilray Brands Stock Up 14.2%

The company has a market capitalization of $917.25 million, a price-to-earnings ratio of -0.58 and a beta of 2.00. The company has a debt-to-equity ratio of 0.19, a current ratio of 2.79 and a quick ratio of 1.66. The firm’s fifty day moving average price is $7.03 and its 200-day moving average price is $9.54.

Tilray Brands (NASDAQ:TLRY – Get Free Report) last released its quarterly earnings data on Wednesday, April 1st. The company reported ($0.24) earnings per share for the quarter, missing the consensus estimate of ($0.14) by ($0.10). The firm had revenue of $206.73 million for the quarter, compared to analyst estimates of $201.35 million. Tilray Brands had a negative net margin of 156.51% and a negative return on equity of 3.31%. During the same period last year, the business earned ($0.87) EPS. Sell-side analysts expect that Tilray Brands, Inc. will post -0.55 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, Director David G. Hopkinson sold 33,556 shares of Tilray Brands stock in a transaction dated Tuesday, April 21st. The stock was sold at an average price of $6.94, for a total transaction of $232,878.64. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 0.84% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in TLRY. Tidal Investments LLC boosted its position in Tilray Brands by 15.0% during the 2nd quarter. Tidal Investments LLC now owns 28,971,835 shares of the company’s stock worth $12,006,000 after buying an additional 3,776,410 shares during the period. Millennium Management LLC increased its position in Tilray Brands by 281.0% in the 3rd quarter. Millennium Management LLC now owns 4,942,319 shares of the company’s stock valued at $8,550,000 after acquiring an additional 3,645,060 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in Tilray Brands in the 3rd quarter valued at approximately $5,813,000. Ausdal Financial Partners Inc. bought a new position in shares of Tilray Brands during the second quarter valued at $939,000. Finally, Scientech Research LLC bought a new position in shares of Tilray Brands during the third quarter valued at $1,748,000. Institutional investors own 9.35% of the company’s stock.

About Tilray Brands

(Get Free Report)

Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.

Tilray’s product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.